Huawei Digital Power has launched a new generation of smart string grid-forming power conversion system (PCS) at SNEC 2026 in ...

Two Bristol Myers Squibb (BMS) researchers at work. BMS will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology and immunology, the companies said today, through ...

A first-in-class bispecific antibody-drug conjugate that Bristol Myers Squibb paid $800 million for has shown strong phase 3 ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines. The deal could be ...

Bristol Myers Squibb (BMS) is the latest big pharmaceutical company to collaborate with Jiangsu Hengrui Pharmaceuticals, a Chinese drugmaker that has become a popular partner for international firms ...

Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 2:00 PM EDTCompany ParticipantsCharles Triano ...

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next ...

Roche said its $4.3 billion takeover of Spark Therapeutics remained on track despite failing to get enough votes to clinch the deal while U.S. regulators continued scrutinizing it. Bristol Myers ...

Biopharmaceutical giant Bristol-Myers Squibb is bringing Anthropic’s flagship Claude product to more than 30,000 of its employees—deepening its use of artificial intelligence and AI agents for a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The New Jersey-based ...